Lupin pharmaceuticals recieves approval for ANDA
Lupin's Escitalopram tablets are the AB rated generic equivalent of Lexapro tablets indicated for treatment of major depressive disorder. The brand product had annual sales of approximately $2.6 bn for the month end March 2008 based on IMS health sales data.
With this approval, the cummulative ANDA approvals stands at 30(including 3 tentative approvals) with 33 pending approvals from USFDA.